In Silico Screening of Drugs That Target Different Forms of E Protein for Potential Treatment of COVID-19
Recently the E protein of SARS-CoV-2 has become a very important target in the potential treatment of COVID-19 since it is known to regulate different stages of the viral cycle. There is biochemical evidence that E protein exists in two forms, as monomer and homopentamer. An in silico screening anal...
Saved in:
Main Authors: | Gema Lizbeth Ramírez Salinas (Author), Alejandro López Rincón (Author), Jazmín García Machorro (Author), José Correa Basurto (Author), Marlet Martínez Archundia (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Is there something else besides the proapoptotic AVPI-segment in the Smac/DIABLO protein?
by: Georgina Victoria-Acosta, et al.
Published: (2016) -
Trypanothione reductase: a target protein for a combined in vitro and in silico screening approach.
by: Mathias Beig, et al.
Published: (2015) -
Daidzein and Equol: Ex Vivo and In Silico Approaches Targeting COX-2, iNOS, and the Canonical Inflammasome Signaling Pathway
by: Yazmín K. Márquez-Flores, et al.
Published: (2024) -
Editorial: Recent trends in anti-cancer drug discovery by in silico methods
by: Carmen Cerchia, et al.
Published: (2024) -
In Silico Structural Protein Evaluation of the Phenylalanine Hydroxylase p.(Tyr77His) Variant Associated with Benign Hyperphenylalaninemia as Identified through Mexican Newborn Screening
by: Marcela Vela-Amieva, et al.
Published: (2023)